| Ginger Isom-batz, MD | |
|
10501 N. Central Expwy, Suite 200, Dallas, TX 75231-2200 | |
| (214) 360-1535 | |
| (214) 360-1534 |
| Full Name | Ginger Isom-batz |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 24 Years |
| Location | 10501 N. Central Expwy, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366545873 | NPI | - | NPPES |
| 8FW629 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | M4197 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Presbyterian Hospital Dallas | Dallas, TX | Hospital |
| Texas Health Presbyterian Hospital Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Clinics Of North Texas, Pllc | 5496736415 | 68 |
News Archive
Lonza Houston, Inc., a global leader in biological, cell and viral gene therapy manufacturing, and Benitec Biopharma, a clinical stage biotechnology company commercializing a patented gene-silencing technology, DNA-directed RNA interference (ddRNAi), today announced that they have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process for Benitec's ddRNAi-based, Adeno-Associated Virus (AAV)-delivered products intended for therapeutic use in humans.
The American Association for Cancer Research today announces a $200,000 gift from the Breast Cancer Research Foundation which will create the BCRF-AACR Fund for Translational Breast Cancer Research.
Researchers have described how the most common gene mutation found in acute myeloid leukaemia starts the process of cancer development and how it can cooperate with a well-defined group of other mutations to cause full-blown leukaemia.
The staff at Stony Brook Southampton Hospital is accustomed to the number of patients tripling or even quadrupling each summer when wealthy Manhattanites flee the city for the Hamptons. But this year, the COVID pandemic has upended everything.
The Court found two Novamont patents to be fully valid and a third patent to be partially invalid while also finding that Novamont had not provided proof of the infringement. Not entering into the merit of the case, the Court noted that the analyses on samples of the products of the summoned companies had not been conducted in a two-party process.
› Verified 7 days ago
| Entity Name | Urology Clinics Of North Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780971549 PECOS PAC ID: 5496736415 Enrollment ID: O20040526000711 |
News Archive
Lonza Houston, Inc., a global leader in biological, cell and viral gene therapy manufacturing, and Benitec Biopharma, a clinical stage biotechnology company commercializing a patented gene-silencing technology, DNA-directed RNA interference (ddRNAi), today announced that they have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process for Benitec's ddRNAi-based, Adeno-Associated Virus (AAV)-delivered products intended for therapeutic use in humans.
The American Association for Cancer Research today announces a $200,000 gift from the Breast Cancer Research Foundation which will create the BCRF-AACR Fund for Translational Breast Cancer Research.
Researchers have described how the most common gene mutation found in acute myeloid leukaemia starts the process of cancer development and how it can cooperate with a well-defined group of other mutations to cause full-blown leukaemia.
The staff at Stony Brook Southampton Hospital is accustomed to the number of patients tripling or even quadrupling each summer when wealthy Manhattanites flee the city for the Hamptons. But this year, the COVID pandemic has upended everything.
The Court found two Novamont patents to be fully valid and a third patent to be partially invalid while also finding that Novamont had not provided proof of the infringement. Not entering into the merit of the case, the Court noted that the analyses on samples of the products of the summoned companies had not been conducted in a two-party process.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ginger Isom-batz, MD 3600 Gaston Ave, Suite 1205, Dallas, TX 75246-1800 Ph: (214) 692-8262 | Ginger Isom-batz, MD 10501 N. Central Expwy, Suite 200, Dallas, TX 75231-2200 Ph: (214) 360-1535 |
News Archive
Lonza Houston, Inc., a global leader in biological, cell and viral gene therapy manufacturing, and Benitec Biopharma, a clinical stage biotechnology company commercializing a patented gene-silencing technology, DNA-directed RNA interference (ddRNAi), today announced that they have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process for Benitec's ddRNAi-based, Adeno-Associated Virus (AAV)-delivered products intended for therapeutic use in humans.
The American Association for Cancer Research today announces a $200,000 gift from the Breast Cancer Research Foundation which will create the BCRF-AACR Fund for Translational Breast Cancer Research.
Researchers have described how the most common gene mutation found in acute myeloid leukaemia starts the process of cancer development and how it can cooperate with a well-defined group of other mutations to cause full-blown leukaemia.
The staff at Stony Brook Southampton Hospital is accustomed to the number of patients tripling or even quadrupling each summer when wealthy Manhattanites flee the city for the Hamptons. But this year, the COVID pandemic has upended everything.
The Court found two Novamont patents to be fully valid and a third patent to be partially invalid while also finding that Novamont had not provided proof of the infringement. Not entering into the merit of the case, the Court noted that the analyses on samples of the products of the summoned companies had not been conducted in a two-party process.
› Verified 7 days ago
Dr. Xiaosong Meng, M.D., PH.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000 | |
Bruce Jeremy Schlomer, MD Urology Medicare: Medicare Enrolled Practice Location: 2350 N Stemmons Fwy, Suite D-4300, Mc F4.04, Dallas, TX 75207 Phone: 214-456-2444 | |
Dr. Jodi Antonelli, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-5615 Fax: 214-648-8786 | |
Dr. Eric Bryan Smith, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3417 Gaston Ave, Ste 830, Dallas, TX 75246 Phone: 214-826-6235 Fax: 214-828-4633 | |
Gary Evan Lemack, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-8765 | |
Dr. Homa Jackson Porter Ii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8230 Walnut Hill Ln, Suite 700, Dallas, TX 75231 Phone: 214-691-1902 Fax: 214-987-1845 | |
Dr. Michelle Leigh Mcdonald, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 |